Interestingly, the survey results suggest that currently cardiologists do not assume that cardiovascular risk reduction is a GLP-1 class effect
I have very tiny, jumpy veins and a strong vagovasal reaction, which is a worst nightmare for phlebotomy
Takeaways The latest batch of warning letters reinforces a set of themes that have become increasingly consistent across enforcement actions involving compounded GLP1 products and related telehealth marketing
However, even when prompted, cardiologists frequently reported being unaware of a drug, especially Mounjaro, while again Ozempic stands out as having greatest familiarity
patents, and has been affiliated with various academic and scientific institutions
These natural alternatives can be used alongside diet, exercise and other lifestyle changes